Skip to main content
. 2023 Nov 23;14:1304466. doi: 10.3389/fimmu.2023.1304466

Figure 9.

Figure 9

Prediction of SKCM patients’ sensitivity to chemotherapeutic drugs. (A) Cluster 2 manifested heightened IC50. (B) Cluster 1 manifested heightened IC50.